Jacobs Levy Equity Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.5M Sell
2,283,424
-356,575
-14% -$7.13M 0.2% 118
2025
Q4
$43.1M Sell
2,639,999
-307,990
-10% -$4.65M 0.17% 125
2025
Q3
$34.5M Buy
2,947,989
+550,250
+23% +$7.17M 0.14% 145
2025
Q2
$27.8M Buy
2,397,739
+1,231,016
+106% +$11.2M 0.11% 177
2025
Q1
$10.2M Buy
1,166,723
+1,135,356
+3,620% +$14.3M 0.04% 336
2024
Q4
$450K Buy
+31,367
New +$495K ﹤0.01% 825
2024
Q3
Sell
-101,301
Closed -$1.97M 1052
2024
Q2
$1.97M Buy
101,301
+4,129
+4% +$108K 0.01% 597
2024
Q1
$3.65M Buy
+97,172
New +$4.27M 0.02% 486

Other funds holding TXG